Study of DF6215 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
Dragonfly Therapeutics
Hoffmann-La Roche
ViroMissile, Inc.
AstraZeneca
Washington University School of Medicine
Pfizer
Tizona Therapeutics, Inc
M.D. Anderson Cancer Center
USWM, LLC (dba US WorldMeds)
Adaptimmune
xCures
Daiichi Sankyo
Second Life Therapeutics
Onchilles Pharma Inc
University Health Network, Toronto
Elephas
Novartis
The Netherlands Cancer Institute
Elephas
Inhibrx Biosciences, Inc
TScan Therapeutics, Inc.
TScan Therapeutics, Inc.
Bolt Biotherapeutics, Inc.
Tempus AI
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
Actym Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center
British Columbia Cancer Agency
Memgen, Inc.
Washington University School of Medicine
Palleon Pharmaceuticals, Inc.
Institut Cancerologie de l'Ouest
Incyte Corporation
MacroGenics
Milton S. Hershey Medical Center
Providence Health & Services
Marengo Therapeutics, Inc.
Genentech, Inc.
University of California, San Diego
UNICANCER
University of Colorado, Denver
DEKA Biosciences
Rapa Therapeutics LLC
Columbia University
Thomas Jefferson University
Tempus AI
Revolution Medicines, Inc.
Arbeitsgemeinschaft medikamentoese Tumortherapie
University Medical Center Groningen